Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy

European Heart Journal

Volumn 35, Issue 39, 2014, Pages 2706-2713

  Gruner, Christiane ^a,b   Chan, Raymond H ^c   Crean, Andrew ^a   Rakowski, Harry ^a   Rowin, Ethan J ^d   Care, Melanie ^e,f   Deva, Djeven ^a   Williams, Lynne ^a   Appelbaum, Evan ^c   Gibson, C Michael ^c   Lesser, John R ^g   Haas, Tammy S ^g   Udelson, James E ^d   Manning, Warren J ^c   Siminovitch, Katherine ^e,f   Ralph Edwards, Anthony C ^a   Rastegar, Hassan ^d   Maron, Barry J ^g   Maron, Martin S ^d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Cardiovascular magnetic resonance; Genotype; Hypertrophic cardiomyopathy; Muscle bundle

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; CARDIAC MUSCLE; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; DNA MUTATIONAL ANALYSIS; GENETICS; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PATHOLOGY; PEDIGREE; PHENOTYPE; PROCEDURES;

ADULT; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENOTYPE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUTATION; MYOCARDIUM; PEDIGREE; PHENOTYPE; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84904665193     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu154     Document Type: Article

References (27)

1. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:220-228.
2. Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De SantisM, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;52:559-566.
3. Kim DH, Handschumacher MD, Levine RA, Choi YS, Kim YJ, Yun SC, Song JM, Kang DH, Song JK. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction. Circulation 2010;122:1298-1307.
4. Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 2011;124:40-47.
5. Cavalcante JL, Barboza JS, Lever HM. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy. Prog Cardiovasc Dis 2012;54:517-522.
6. Maron MS, Hauser TH, Dubrow E, Horst TA, Kissinger KV, Udelson JE, Manning WJ. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007; 100:1293-1298.
7. Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 2008;101:668-673.
8. Germans T, Wilde AA, Dijkmans PA, ChaiW, Kamp O, Pinto YM, van Rossum AC. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-2523.
9. Brouwer WP, Germans T, Head MC, van der Velden J, HeymansMW, Christiaans I, Houweling AC, Wilde AA, van Rossum AC. Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophicHCMmutation carriers. Eur Heart J Cardiovasc Imaging 2012;13:292-297.
10. Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2012;5:441-447.
11. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, Mahrholdt H. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-887.
12. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010;3:51-58.
13. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S,Wage R,Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, SheppardMN,Elliott PM, Pennell DJ, Prasad SK. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-874.
14. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-1374.
15. MoonJC, McKenna WJ,McCrohonJA, Elliott PM, SmithGC,Pennell DJ.Toward clinical risk assessment in hypertrophic cardiomyopathy with gadoliniumcardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567.
16. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e783-e831.
17. Klues HG, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 1991;84:1188-1197.
18. Rowin EJ, Maron BJ, Lesser JR, Rastegar H, Maron MS. Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management. Am J Cardiol 2013;111:1677-1679.
19. Harrigan CJ, PetersDC,Gibson CM,Maron BJ, ManningWJ,MaronMS, AppelbaumE. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 2011;258:128-133.
20. Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol 2012;60:705-715.
21. Moon JC, Fisher NG, McKenna WJ, Pennell DJ.Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004;90:645-649.
22. Rowin EJ, Maron MS, Lesser JR, Maron BJ.CMRwith late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012;5:119-122.
23. Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonzalez A, Colan SD, Seidman JG, Diez J, Seidman CE. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010;363: 552-563.
24. Cardim N, Perrot A, Ferreira T, Pereira A, Osterziel KJ, Reis RP, Correia JF. Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy. Am J Cardiol 2002;90:128-132.
25. De S, Borowski AG,Wang H, Nye L, Xin B, Thomas JD, Tang WH. Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy. Am Heart J 2011; 162:262-267 e263.
26. Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg 2010;140:317-324.
27. Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy-the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med 2007;4:503-512.